Computer-aided detection (CAD) and radiation therapy firm iCAD is poised to offer 2.4 million shares of common stock at $11 per share.
The offering is expected to close on or near March 17, subject to certain closing conditions.
The net proceeds are expected to be approximately $24.5 million, which the company intends to use for working capital and other general corporate purposes.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
